447 related articles for article (PubMed ID: 28915960)
1. Pleiotropic effects of metformin to rescue statin-induced muscle injury and insulin resistance: A proposed mechanism and potential clinical implications.
Carris NW; Tipparaju SM; Magness DJ; Chapalamadugu KC; Magness RR
Med Hypotheses; 2017 Sep; 107():39-44. PubMed ID: 28915960
[TBL] [Abstract][Full Text] [Related]
2. Metformin's impact on statin-associated muscle symptoms: An analysis of ACCORD study data and research materials from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center.
Carris NW; Tsalatsanis A; Tipparaju SM; Cheng F; Magness RR; Kumar A
Diabetes Obes Metab; 2018 Aug; 20(8):1994-1999. PubMed ID: 29577553
[TBL] [Abstract][Full Text] [Related]
3. Rationale for investigating metformin as a protectant against statin-associated muscle symptoms.
Elsaid O; Taylor B; Zaleski A; Panza G; Thompson PD
J Clin Lipidol; 2017; 11(5):1145-1151. PubMed ID: 28764958
[TBL] [Abstract][Full Text] [Related]
4. Diabetogenic Action of Statins: Mechanisms.
Carmena R; Betteridge DJ
Curr Atheroscler Rep; 2019 Apr; 21(6):23. PubMed ID: 31037345
[TBL] [Abstract][Full Text] [Related]
5. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
6. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.
Newman CB; Preiss D; Tobert JA; Jacobson TA; Page RL; Goldstein LB; Chin C; Tannock LR; Miller M; Raghuveer G; Duell PB; Brinton EA; Pollak A; Braun LT; Welty FK;
Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):e38-e81. PubMed ID: 30580575
[TBL] [Abstract][Full Text] [Related]
7. Rationale for the use of metformin and exercise to counteract statin-associated side effects.
Haxhi J; Thompson PD
Int J Clin Pract; 2021 May; 75(5):e13900. PubMed ID: 33277775
[TBL] [Abstract][Full Text] [Related]
8. Statin treatment and new-onset diabetes: a review of proposed mechanisms.
Brault M; Ray J; Gomez YH; Mantzoros CS; Daskalopoulou SS
Metabolism; 2014 Jun; 63(6):735-45. PubMed ID: 24641882
[TBL] [Abstract][Full Text] [Related]
9. Statin-Associated Diabetes Mellitus: Review and Clinical Guide.
Backes JM; Kostoff MD; Gibson CA; Ruisinger JF
South Med J; 2016 Mar; 109(3):167-73. PubMed ID: 26954655
[TBL] [Abstract][Full Text] [Related]
10. Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance.
Banach M; Malodobra-Mazur M; Gluba A; Katsiki N; Rysz J; Dobrzyn A
Curr Pharm Des; 2013; 19(27):4904-12. PubMed ID: 23278491
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Secondary to Treatment with Statins.
Laakso M; Kuusisto J
Curr Diab Rep; 2017 Feb; 17(2):10. PubMed ID: 28155189
[TBL] [Abstract][Full Text] [Related]
12. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
13. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
[TBL] [Abstract][Full Text] [Related]
14. An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials.
Sun J; Yuan Y; Cai R; Sun H; Zhou Y; Wang P; Huang R; Xia W; Wang S
BMJ Open; 2015 Mar; 5(3):e007280. PubMed ID: 25818277
[TBL] [Abstract][Full Text] [Related]
15. New onset diabetes mellitus induced by statins: current evidence.
Chrysant SG
Postgrad Med; 2017 May; 129(4):430-435. PubMed ID: 28276790
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
[TBL] [Abstract][Full Text] [Related]
17. Statin treatment is associated with insulin sensitivity decrease in type 1 diabetes mellitus: A prospective, observational 56-month follow-up study.
Duvnjak L; Blaslov K
J Clin Lipidol; 2016; 10(4):1004-1010. PubMed ID: 27578133
[TBL] [Abstract][Full Text] [Related]
18. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice.
Finegold JA; Manisty CH; Goldacre B; Barron AJ; Francis DP
Eur J Prev Cardiol; 2014 Apr; 21(4):464-74. PubMed ID: 24623264
[TBL] [Abstract][Full Text] [Related]
19. Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.
Mitchell PL; Nachbar R; Lachance D; St-Pierre P; Trottier J; Barbier O; Marette A
Diabetes Obes Metab; 2017 Mar; 19(3):313-319. PubMed ID: 27800648
[TBL] [Abstract][Full Text] [Related]
20. Statins and diabetes risk: how real is it and what are the mechanisms?
Robinson JG
Curr Opin Lipidol; 2015 Jun; 26(3):228-35. PubMed ID: 25887679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
